Eric S. Soehnlen, Ph.D.
Affiliations: | 2012 | Chemistry | Kent State University, Kent, OH, United States |
Area:
Analytical Chemistry, NanoscienceGoogle:
"Eric Soehnlen"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Soumitra Basu | grad student | 2012 | Kent State | |
| (Novel Nanomaterials for Tumor Targeted Imaging and Therapy.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Beals N, Thiagarajan PS, Soehnlen E, et al. (2017) Five-Part Pentameric Nanocomplex Shows Improved Efficacy of Doxorubicin in CD44+ Cancer Cells. Acs Omega. 2: 7702-7713 |
| Shoffstall AJ, Everhart LM, Varley ME, et al. (2013) Tuning ligand density on intravenous hemostatic nanoparticles dramatically increases survival following blunt trauma. Biomacromolecules. 14: 2790-7 |
| Das A, Soehnlen E, Woods S, et al. (2011) VEGFR-2 targeted cellular delivery of doxorubicin by gold nanoparticles for potential antiangiogenic therapy Journal of Nanoparticle Research. 13: 6283-6290 |
| Shokouhimehr M, Soehnlen ES, Hao J, et al. (2010) Dual purpose Prussian blue nanoparticles for cellular imaging and drug delivery: A new generation of T1-weighted MRI contrast and small molecule delivery agents Journal of Materials Chemistry. 20: 5251-5259 |
| Shokouhimehr M, Soehnlen ES, Khitrin A, et al. (2010) Biocompatible Prussian blue nanoparticles: Preparation, stability, cytotoxicity, and potential use as an MRI contrast agent Inorganic Chemistry Communications. 13: 58-61 |